Yonekura S, Endo Y, Fujii H, Ishikawa M, et al. Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy. J Dermatol 2023 Jul 3. doi: 10.1111/1346-8138.16873.
PMID: 37400887